COVID-19 Pipeline Drugs and Companies Insight Report: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments
DelveInsight’s “COVID-19 Pipeline Insight” report provides comprehensive insights about key companies and pipeline drugs in the COVID-19 pipeline landscapes. It comprises COVID-19 pipeline drug profiles, including clinical and non-clinical stage products. It also includes the COVID-19 therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive COVID-19 pipeline products.
Some of the key takeaways of the COVID-19 Pipeline Report:
-
Companies across the globe are diligently working toward the development of novel treatment therapies with a considerable amount of success over the years. Key players, such as, Amgen, Corvus Pharmaceuticals, Fulcrum Therapeutics, Synairgen Research. Revive Therapeutics, Novavax, Valneva, etc., are developing therapies for the treatment of COVID-19.
-
Emerging therapies such as Otezla (Apremilast), CPI-006, Losmapimod, SNG001 (Interferon beta-1a), Bucillamine, NVX-CoV2373, VLA2001, are expected to have a significant impact on the COVID-19 market in the coming years.
Get an overview of pipeline landscape @ COVID-19 Clinical Trials Analysis
COVID-19 Overview
COVID-19 is an infectious disease caused by a newly discovered coronavirus, i.e., SARS-CoV-2. It spreads primarily through droplets of saliva or discharge from the nose when an infected person coughs or sneezes. CoVs are enveloped, positive-stranded RNA viruses with nucleocapsids. The pathogenic mechanism which causes pneumonia seems to be complex
COVID-19 Emerging Drugs
-
Otezla (Apremilast): Amgen
-
CPI-006: Corvus Pharmaceuticals
-
Losmapimod: Fulcrum Therapeutics
-
SNG001 (Interferon beta-1a): Synairgen Research
-
Bucillamine: Revive Therapeutics
-
NVX-CoV2373: Novavax
-
VLA2001: Valneva
For further information, refer to the detailed report @ COVID-19 Pipeline Therapeutics
Scope of COVID-19 Pipeline Drug Insight
-
Coverage: Global
-
Major Players: Amgen, Corvus Pharmaceuticals, Fulcrum Therapeutics, Synairgen Research. Revive Therapeutics, Novavax, Valneva, and others.
-
Pipeline Therapies: Otezla (Apremilast), CPI-006, Losmapimod, SNG001 (Interferon beta-1a), Bucillamine, NVX-CoV2373, VLA2001, and others.
Table of Contents
1 |
COVID-19 Report Introduction |
2 |
COVID-19 Executive Summary |
3 |
COVID-19 Overview |
4 |
COVID-19- Analytical Perspective In-depth Commercial Assessment |
5 |
COVID-19 Pipeline Therapeutics |
6 |
COVID-19 Late Stage Products (Phase II/III) |
7 |
COVID-19 Mid Stage Products (Phase II) |
8 |
COVID-19 Early Stage Products (Phase I) |
9 |
COVID-19 Preclinical Stage Products |
10 |
COVID-19 Therapeutic Assessment |
11 |
COVID-19 Inactive Products |
12 |
Company-University Collaborations (Licensing/Partnering) Analysis |
13 |
COVID-19 Key Companies |
14 |
COVID-19 Key Products |
15 |
COVID-19 Unmet Needs |
16 |
COVID-19 Market Drivers and Barriers |
17 |
COVID-19 Future Perspectives and Conclusion |
18 |
COVID-19 Analyst Views |
19 |
Appendix |
20 |
About DelveInsight |
Get a customized pipeline report @ COVID-19 Drugs Pipeline Report
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/